Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

India to assess price of all new medicines

Even new combinations and dosages will need approval before launch

- PMLiVE

Early approval for Amgen’s breakthrough leukaemia drug

32% of patients in remission after at least four weeks of Blincyto infusion

- PMLiVE

HealthStar PR appoints executive VP

David Bashaw has experience at MSLGROUP, Ogilvy and Edelman

- PMLiVE

Sharp Packaging appoints divisional managing director

Mike O’Hara has over 25 years’ experience

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

Ziarco appoints Mike Grey to board of directors

He is chairman and CEO of Reneo Pharmaceuticals

- PMLiVE

Hackers target deal-rich pharma sector

Look to gain access to insider information for stock market gain

23andMe launches personal genome service in the UK

Mail-order genetic service will cost £125

- PMLiVE

Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

Bayer symbol

Bayer puts research at heart of business growth

Says R&D-to-sales ratio will increase

Sanofi reception

Sanofi and Evotec discuss high-level outsourcing alliance

Partnership to focus on cancer drug discovery

- PMLiVE

Biosimilar Remicade reaches market in Japan and India

Nippon Kayaku’s version of arthritis drug was approved in July

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links